Boston Scientific to Pay Johnson & Johnson $1.73B Settlement
Johnson & Johnson (JNJ) and Boston Scientific (BSX) said today that they have agreed on a settlement in three stent-related patent disputes. Boston Scientific will pay a total of $1.73 billion to settle suits in which Johnson & Johnson alleged patent infringement on various stent products.
Credit: Market News Video
Copyright: Market News Video
Published by Grab Networks
A resource for website publishers who want to embed quality, licensed content on a wide variety of topics. View profile



